The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...

As monotherapy for treatment of adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations, after failure of platinum-based therapy.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Both the US Food and Drug Administration (FDA), through the Orphan Drug Act, and the European Medicines Agency (EMA), through ... alongside the International Rare Diseases Research Consortium ...

International reliance is a mechanism ... accordingly announced that from 2024 the Medicines and Healthcare products Regulatory Agency (MHRA) will adopt a new regulatory model, allowing for ...

China's tariffs - due to begin next Monday - would also apply to US oil and farm machinery, but more talks are due this week.

Amid the military posturing, economic sanctions, and political power struggles shaping the US-China rivalry, intellectual property (IP) disputes rema ...

WIPO, which became a UN-specialized agency in 1974, has positioned itself as the leading force in global IP protection. Unlike TRIPS, which enforces trade-based IP rules, WIPO oversees 27 broad IP ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...